Seattle, Washington, United States
I am a strategic product marketer with 9 years of experience in the life sciences industry, specializing in product management, program strategy, marketing, and establishing strategic partnerships. With a strong foundation in oncology, immunology, cell and gene therapy, and clinical trials, I excel in developing and implementing GTM strategies, strategic communications, driving growth, and improving internal operations. I'm passionate about data-driven decision-making and cross-functional collaboration has led to numerous successful product launches, including the nCounter® Pro Analysis System. As a creative problem solver, I've been tapped quite a few times for turnaround programs (think - refreshing mature product lines, getting a product launch over the finish line, or reinvigorating sales teams). Outside of business hours, I'm an active community organizer, mentor, and volunteer. I lead a non-profit board to organize local mentoring programs, and professional development and networking events. I'm also a home DIY enthusiast and love brining my strategic and creative skills to personal projects.
I support the North America Chromatography and Mass Spectrometry business with special focus on -omics applications.
Strong stakeholder manager responsible for driving strategic initiatives and new product launches for the nCounter® brand. • Orchestrated an in-depth portfolio analysis to uncover opportunities for increasing org effectiveness by streamlining product offerings, working closely with different stakeholder groups to develop strategic and financial business recommendations for the senior executive team. • Initiated a comprehensive sales training program to enhance proficiency in product features, positioning, and customer targeting through in-depth training and coaching. This improved performance, leading to a 66% reduction in the average time to first sale for new hires. • Spearheaded the rebrand of the company’s flagship product line, including development of new buyer personas, messaging, and sales collateral informed by extensive market research and historical sales analysis; the resulting changes resulted in a 20% growth in sales funnel leads post-launch. • Owned the GTM strategy for the launch of various new instruments and molecular assays by driving collaboration and alignment across the organization to ensure smooth execution across the organization. • Led an initiative that reduced customer churn by 30% after analyzing customer sales history and outreach data to identify opportunities to automate and scale key parts of the sales cycle to increase retention. • Successfully championed the restructuring of the sales organization to better align resources with forecasts, while still increasing team performance and close rates, thanks to a more focused field marketing and technical sales team. • Launched a new feature request workflow to support a more agile product development process, leading to improved voice of customer integration and faster responses to field feedback to improve customer satisfaction.
• Led the preparation for the 510k and PMA submission of a CDx assay while working closely with Regulatory, Clinical, Legal, and strategic drug development partners to ensure acceptance by the FDA. • Initiated collaborative partner relationships for numerous early & late-stage clinical trial programs with ownership over site selection, study budgets, study budgets, governance, and contract negotiations. • Collaborated closely with Product Management to develop an updated pricing structure for services based on competitive market and internal cost analysis. • Spearheaded a cross-functional project to transition contracts and customer relationships to an M&A partner, resulting in more efficient consumable orders, revenue forecasts, and a seamless customer experience. • Reduced clinical trial costs by 5% by refining the volume of clinical trial data collected via cross-functional breakouts. • Developed strategy to drive buy-in on risk management program resulting in reduced time spent in mitigation. • Accelerated study startup timelines by 15% to meet revenue milestones by streamlining RFP process and training.
Established collaborative vendor and clinical site relationships as lead monitor for various registrational studies through frequent and clear communication to ensure alignment.
•Oversaw planning and execution of 14 professional development and networking events each year to increase community engagement. • Secured funding from the City of Seattle’s Key Industries and Workforce Development Taskforce to develop an executive-level coaching program and to fund a series of downtown activation networking events. • Managed a dispersed team of 18+ volunteer board members while ensuring accountability and follow-through on key chapter initiatives. • Led budgeting, board training, and community outreach, while growing membership 10% every year.
Coordinated studies throughout project lifecycle. Translated contracts into protocol templates. Managed flow of data for analysis.
Martin-Oshima Laboratory in the Department of Pathology
Department of Bioethics and Humanities